DDD Partners LLC has significantly increased its investment in Danaher Corporation, raising its stake by an impressive 7,732.8% during the third quarter of 2023. As reported by HoldingsChannel.com, the institutional investor now holds 92,270 shares of the company, having acquired an additional 91,092 shares during the quarter. This investment makes Danaher Corporation approximately 1.2% of DDD Partners LLC’s total holdings, marking it as the firm’s 27th largest investment. The total value of DDD Partners LLC’s holdings in Danaher is estimated at $18.29 million based on its most recent filing with the U.S. Securities and Exchange Commission (SEC).
Numerous other institutional investors have also engaged with Danaher’s stock in recent months. For instance, WFA of San Diego LLC entered a new position valued at $26,000 in the second quarter, while Howard Hughes Medical Institute purchased shares worth $27,000. TruNorth Capital Management LLC and Tripletail Wealth Management LLC also made new investments during the third quarter, valued at approximately $28,000 and $31,000, respectively. Heartwood Wealth Advisors LLC joined the trend with a position worth about $37,000. Currently, institutional and hedge fund investors collectively own 79.05% of Danaher Corporation’s stock.
Analyst Ratings and Market Performance
Recent evaluations from several research firms indicate a positive outlook for Danaher Corporation. Evercore has reiterated an “outperform” rating, setting a price target of $254.00. Similarly, Deutsche Bank Aktiengesellschaft maintained a “buy” rating, while Weiss Ratings assigned a “hold (c)” rating. Robert W. Baird and TD Cowen have also issued favorable targets, with respective price objectives of $251.00 and a “buy” rating.
Overall, twenty analysts have rated Danaher with a Buy rating, while three have opted for a Hold rating. According to data from MarketBeat.com, Danaher currently holds an average rating of “Moderate Buy” with an average price target of $253.86.
As of the latest trading session, Danaher shares opened at $212.37. The company has demonstrated substantial price fluctuation over the past year, with a low of $171.00 and a high of $242.80. Danaher boasts a market capitalization of $150.01 billion, a price-to-earnings (P/E) ratio of 42.14, and a beta of 0.91. The stock has also performed well in terms of moving averages, with a 50-day simple moving average of $228.63 and a 200-day average of $215.46.
Financial Results and Dividend Announcements
Danaher Corporation recently reported its earnings for the last quarter on January 27, 2024, delivering earnings per share (EPS) of $2.23. This figure surpassed analysts’ estimates of $2.14 by $0.09. The company recorded a revenue of $6.84 billion, exceeding the consensus estimate of $6.79 billion. This revenue figure reflects a 4.6% increase compared to the same quarter last year.
Additionally, Danaher recently declared a quarterly dividend of $0.32, paid on January 30, 2024, to shareholders recorded as of December 26, 2023. This dividend equates to an annualized payout of $1.28, yielding 0.6%. The company’s current dividend payout ratio stands at 25.40%.
In other developments, Teri List, a director of Danaher, sold 3,298 shares on November 18, 2023, at an average price of $226.50, totaling approximately $746,997. Following this transaction, List retains 20,762 shares valued around $4.70 million. This sale represents a 13.71% decrease in her position, a detail disclosed in a filing with the SEC.
Danaher Corporation is a global leader in science and technology, focusing on the design, manufacturing, and marketing of products and services across life sciences, diagnostics, and environmental sectors. The company’s diverse portfolio includes analytical instruments, laboratory consumables, software solutions, and maintenance programs, impacting research, clinical testing, and industrial monitoring worldwide.
For further insights into Danaher’s performance and investment updates, visit HoldingsChannel.com for the latest 13F filings and insider trades related to Danaher Corporation (NYSE:DHR).
